Phase I/II study of biweekly administration regimen of paclitaxel combined with CPT-11 [irinotecan] in patients with second line chemotherapy of inoperable or recurrent gastric cancer
Withdrawn prior to enrolment
Phase of Trial: Phase I/II
Latest Information Update: 16 Feb 2009
At a glance
- Drugs Irinotecan (Primary) ; Paclitaxel (Primary)
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- 16 Feb 2009 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 26 Nov 2005 New trial record.